Evidence map›Paper›PMID 35800453›Full record

ArticleFrontiers in pharmacology2022

Clinical Benefits of Golden-

Yu-Ting Yen, Joo-Hyun Park, Seung-Hyun Kang, Today Su, Howard Cheng, Wu-Che Wen, Shin-Shiou Lin, Yu-Ling Tai, Pei-Ni Chen, Shih-Chang Tsai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Yu-Ting YenDrug Development Center, Institute of New Drug Development, Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Joo-Hyun ParkDepartment of Family Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, South Korea.
Seung-Hyun KangClinical Research Center of H PLUS Yangji Hospital, Seoul, South Korea.
Today SuGolden Biotechnology Corporation, New Taipei City, Taiwan.
Howard ChengGolden Biotechnology Corporation, New Taipei City, Taiwan.
Wu-Che WenGolden Biotechnology Corporation, New Taipei City, Taiwan.
Shin-Shiou LinGolden Biotechnology Corporation, New Taipei City, Taiwan.
Yu-Ling TaiGolden Biotechnology Corporation, New Taipei City, Taiwan.
Pei-Ni ChenGolden Biotechnology Corporation, New Taipei City, Taiwan.
Shih-Chang TsaiDepartment of Biological Science and Technology, China Medical University, Taichung, Taiwan.
Golden Biotech (Taiwan) · TWChina Medical University · TWKorea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-lipid functionAntrodia camphorataantroquinonolaspartate aminotransferase/alanine aminotransferase ratioliver function

Identifiers

PMID35800453
PMCPMC9253287
OpenAlexW4283210626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.